The Use of Serratus Block for Cardiac Surgery

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03237546

Enrollment

Registered

2017-08-02

Start date

2017-07-17

Completion date

2017-11-13

Last updated

2018-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Surgery

Keywords

Robotic Cardiac Surgery

Brief summary

The purpose of this randomized, un-blinded study is to determine if serratus blocks or Patient Controlled Analgesia (PCA)-alone (no block) offer patients adequate pain relief. This study will compare two standard of care pain management options and the patients narcotic requirements in the immediate postoperative period.

Interventions

PROCEDUREAnesthetic regimen including SB

Group receiving general anesthesia with the serratus block

PROCEDUREAnesthetic regimen including SB or no block

Group receiving general anesthesia alone

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 100 Years

Healthy volunteers

Inclusion criteria

* Patients over the age of 18 years of age undergoing robotic cardiac surgery.

Exclusion criteria

* Patients who are not candidates for serratus block

Design outcomes

Primary

Measure	Time frame	Description
Amount of intravenous opiates used during the immediate postoperative period	24 Hours	The primary endpoint of the study will be comparison of the amount of intravenous opiates used during the immediate postoperative period between the 2 groups, the group receiving general anesthesia with the serratus block and the group receiving general anesthesia alone.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026